Survival figures for both AML and ALL vary greatly with age: in the over-65s, only 15% with ALL and 5% with AML live for more than 5 years after diagnosis. For patients at the end of life with acute leukaemia, care needs to be centred on their comfort and palliation of
symptoms. The aim should be to help the patient live well until they die.
This new e-learning course looks at the challenges of recognising end of life care and the practical nursing care needed for these patients. This concise educational resource is ideal for any healthcare professional involved in the treatment of patients end-stage acute leukaemia.
This information was commissioned by Leukaemia Care and compiled by Karger Publishing. For more information on the writer, reviewer and editor please see the PDF booklet.
Completion of this course will take approximately 2 hours and the certificates provided can be used towards your revalidation.
For any queries about the content including references, please email email@example.com.
Please note: This course has been primarily designed for nurses and medical professionals interested in this field. While patients and their loved ones might find the information helpful, this course only provides a medical perspective for end of life care. For support with the information in this course, please contact Leukaemia Care on their help line (Freephone 08088 010 444) or email the support team on firstname.lastname@example.org